Clinical trial for Suicidal Ideation
Official title Recovery Through Inspiration, Support, and Empowerment
ClinicalTrials.gov ID: NCT07051200
What this study is testing
- What it's testing
- The study compares a new peer‑support program to usual care to see if it lowers suicidality, depression, anxiety, and readmission rates.
- Who it's for
- Young adults aged 18‑27 who have been discharged from an acute psychiatric unit and have mental health conditions.
- What's involved
- Participants in the intervention group meet one‑on‑one with a Peer Support Specialist for 4 weeks, then have additional meetings and group sessions over 8 weeks. The control group receives weekly phone check‑ins. All participants complete assessments at specified weeks.
- Time commitment
- The study lasts 8 weeks, with scheduled meetings or phone calls and assessments at weeks 2, 4, 6, and 8.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 27
You may be able to join if
- Chief complaint of suicidal ideation, suicide attempt, depression, and/or anxiety
- discharged from inpatient care or from emergency department
- men and women ages 18-27
You likely can't join if
- primary diagnosis of: substance use disorder, schizophrenia spectrum, intellectual development disorder, autism spectrum disorder (level II or III)
The study team makes the final eligibility decision.
Where it is enrolling
- Dallas, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 27 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Dallas, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.